Magnesium Sulfate Dosing in Pediatric Asthma Exacerbation

Indications for Use

The National Asthma Education and Prevention Program Expert Panel recommends IV magnesium sulfate for severe asthma exacerbations that remain severe after 1 hour of intensive conventional treatment, particularly for life-threatening exacerbations and patients with poor response to initial therapy 1

The National Asthma Education and Prevention Program Expert Panel recommends a standard pediatric dose of 25-75 mg/kg IV (maximum 2 g) administered over 20 minutes for children 2

Magnesium causes bronchial smooth muscle relaxation independent of serum magnesium level, providing a complementary bronchodilator effect, and improves pulmonary function when combined with nebulized β-adrenergic agents and corticosteroids 1

IV magnesium sulfate generally has a favorable safety profile with only minor side effects such as flushing and light-headedness, but monitor for hypotension during administration 1
Rapid infusion may cause hypotension and bradycardia; administer over the recommended 20-minute period 3

The American Academy of Pediatrics recommends beginning with standard therapy, and if exacerbation remains severe after 1 hour of intensive treatment, consider IV magnesium sulfate, administering 25-75 mg/kg (maximum 2 g) over 20 minutes 2, 1

IV magnesium should be used as an adjunct to standard therapy, not as a replacement, and have calcium chloride available if needed to reverse potential magnesium toxicity 1, 3
Nebulized magnesium sulfate is less effective than IV administration but may be considered as an additional adjunct therapy 1

IV magnesium sulfate should be considered for children with life-threatening asthma exacerbations or those whose exacerbations remain severe after 1 hour of intensive conventional treatment (inhaled β2-agonists, anticholinergics, and systemic corticosteroids), as recommended by the American Academy of Allergy, Asthma, and Immunology 4
Magnesium sulfate is not recommended for patients with exacerbations of lower severity, but should be reserved for those with poor response to initial therapy, according to the American Academy of Allergy, Asthma, and Immunology 4

Inhaled magnesium sulfate has been proposed for treatment of mild and moderate exacerbations, though it is generally considered less effective than IV administration, as stated by the European Respiratory Society 5

Consider hospitalization for patients with poor response to treatment, as suggested by the European Respiratory Society 6

In children with severe asthma, the recommended first‑line regimen before adding magnesium sulfate consists of nebulized albuterol 2.5–5 mg every 20 minutes for three doses, nebulized ipratropium bromide 0.5 mg, and systemic corticosteroids (methylprednisolone 1–2 mg/kg IV or prednisone 1–2 mg/kg PO)【7】.

Delivering IV magnesium sulfate over a 20‑minute infusion reduces the likelihood of hypotension and other adverse effects in pediatric patients【8】.
Infusing magnesium faster than 20 minutes significantly increases the risk of hypotension, flushing, and bradycardia【8】.

Magnesium sulfate should not be withheld while awaiting serum magnesium levels because its bronchodilator effect operates independently of baseline magnesium concentrations【8】.